Studies On For Sudden Cardiac Arrest Cases Among Young After Covid: Centre

by Jessica

Indian Council of Medical Research Conducts Studies on Cardiac Arrest Cases After COVID-19 Pandemic

Union Health Minister Mansukh Mandaviya informed Parliament about the rising cases of sudden deaths due to cardiac arrest among young individuals after recovering from COVID-19.

To understand this phenomenon better, the Indian Council of Medical Research (ICMR) is conducting three distinct studies.

The first study is a multi-centric matched case-control study focusing on factors associated with sudden deaths in adults aged 18 to 45 across 40 hospitals and research centers in India.

The second study, also multi-centric and hospital-based, aims to determine the impact of the COVID-19 vaccine on thrombotic events among individuals aged 18 to 45 in 2022 in India.

This research is being conducted in approximately 30 COVID-19 clinical registry hospitals.

The third ongoing study is aimed at establishing the cause of sudden unexplained deaths in young individuals through both virtual and physical autopsies.

To address cardiovascular health issues, the Centre’s Department of Health and Family Welfare provides technical and financial support to states and Union Territories under the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD). This program encompasses infrastructure strengthening, human resource development, health promotion, population-based screening, early diagnosis, and management.

Under NP-NCD, numerous health facilities have been established, including 724 district non-communicable disease clinics, 210 district cardiac care units, 326 district daycare centers, and 6,110 community health center non-communicable disease clinics.

Cardiovascular disease patients receive treatment at various healthcare delivery facilities, including medical colleges, central institutes like AIIMS, central government, and private sector hospitals.

Additionally, the Pradhan Mantri Jan Arogya Yojana (PMJAY) offers health insurance coverage of ₹5 lahks per family per year for secondary or tertiary care hospitalization to over 60 crore beneficiaries, aiming to facilitate accessible and affordable healthcare.

The Rashtriya Arogya Nidhi provides financial assistance to families living below the poverty line for treatment in government hospitals, while the Pradhan Mantri Bhartiya Janaushadhi Pariyojana offers affordable generic medicines through collaboration with state governments.

Furthermore, Affordable Medicines and Reliable Implants for Treatment (AMRIT) pharmacy stores have been established in some hospitals to make cardiovascular drugs available at discounted prices compared to the maximum retail price.

Related Posts